Ovid Therapeutics Inc. Stock Split Ratio
Ovid Therapeutics Inc. (OVID) reported Stock Split Ratio of 46.51% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2018-03-29
- Ovid Therapeutics Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2017-03-31 was 46.51%.
- Ovid Therapeutics Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 46.51%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|
| 2017-12-31 | 46.51% 10-K · filed 2018-03-29 | |||
| 2017-09-30 | 46.51% 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 46.51% 10-Q · filed 2017-08-10 | |||
| 2017-03-31 | 46.51% 10-Q · filed 2017-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |